Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
$2.3M
Market Cap • 26/07/20242014
(há 10 anos)
2016
(8 years ago)
NASDAQ
Listagem
Boca Raton
Sede • FloridaValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ENTOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.